Shaolin Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History
Bought
Maintained
Sold
Other funds holding OACC
Shaolin Capital Management's OACC Position: Q3 2026 in Review
Shaolin Capital Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 42% in Q3 2026, buying an estimated $908K and bringing the position to 285,000 shares worth $3.07M. The position accounts for 0.13% of the portfolio, ranked #143.
Shaolin Capital Management first reported a position in OACC in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.48M in Q4 2024. 47 funds tracked by Wall St. Rank hold OACC as of Q3 2026.
- Shaolin Capital Management held 285,000 shares of Oaktree Acquisition Corp III Life Sciences worth $3.07M as of Q3 2026.
- Shaolin Capital Management bought 84,453 Oaktree Acquisition Corp III Life Sciences shares in Q3 2026, an estimated $908K.
- Oaktree Acquisition Corp III Life Sciences made up 0.13% of Shaolin Capital Management's portfolio in Q3 2026, its #143 holding.
- Shaolin Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 8 quarters since.
- Shaolin Capital Management's Oaktree Acquisition Corp III Life Sciences position peaked at $5.48M in Q4 2024.
- 47 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2026.
Based on Shaolin Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.